Related Experiment Video
Updated: Aug 27, 2025

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
Activated Partial Thromboplastin Time and Mortality in Coronary Artery Bypass Grafting Patients
HuanRui Zhang1, Wen Tian1, Guoxian Qi1
1Department of Geriatric Cardiology, The First Hospital of China Medical University, China.
Insights
Preoperative activated partial thromboplastin time (APTT) levels can predict mortality risk in patients undergoing coronary artery bypass grafting (CABG). A longer APTT, specifically 44 seconds or more, is linked to a higher risk of death after CABG surgery.
Area of Science:
- Cardiology
- Medical Informatics
- Surgical Outcomes
Background:
- Assessing preoperative factors is crucial for predicting outcomes in patients undergoing coronary artery bypass grafting (CABG).
- Activated partial thromboplastin time (APTT) is a routine coagulation test, but its prognostic value in CABG patients is not fully established.
Purpose of the Study:
- To evaluate the prognostic significance of preoperative activated partial thromboplastin time (APTT) in patients undergoing coronary artery bypass grafting (CABG).
- To determine if APTT can serve as an independent predictor of mortality in this patient population.
Main Methods:
- Data were extracted from the Medical Information Mart for Intensive Care III (MIMIC-III) database, including 2,706 patients undergoing CABG.
- Optimal cut-off value for APTT was determined using X-tile software; Cox proportional hazard models and Kaplan-Meier survival analysis were employed.
- Propensity score matching (PSM) was utilized to ensure the robustness of the findings regarding APTT and mortality risk.
Main Results:
- An optimal cut-off value of 44 seconds for preoperative APTT was identified for predicting 4-year mortality.
- Patients with APTT ≥ 44 seconds exhibited a significantly higher risk of all-cause death, both before (HR 1.42) and after PSM (HR 1.47).
- Elevated APTT levels correlated with lower 1-year and 4-year cumulative survival probabilities, and APTT improved the predictive accuracy of existing severity scores.
Conclusions:
- Preoperative activated partial thromboplastin time (APTT) ≥ 44 seconds is associated with an increased risk of mortality in patients undergoing coronary artery bypass grafting (CABG).
- APTT demonstrates potential as a valuable prognostic predictor for long-term outcomes in CABG patients.
Background:
To evaluate the prognostic value of preoperative activated partial thromboplastin time (APTT) in patients who underwent coronary artery bypass grafting (CABG).
Methods:
All data were extracted from the Medical Information Mart for Intensive Care III (MIMIC-III) database. The study population was divided to two groups according to the optimal cut-off value of APTT calculated by X-tile software, and Cox proportional hazard model was used to define independent effect of APTT on 4-year mortality. Survival curves were estimated by the Kaplan-Meier method, and the area under the receiver-operating characteristic curve (AUC) was calculated to compare APTT with other severity scores. Propensity score matching (PSM) analysis were applied to ensure the robustness of this study.
Results:
A total of 2,706 patients were included. The optimal cut-off value of APTT for 4-year mortality was 44 seconds. The Cox proportional hazard model showed that patients with APTT ≥ 44 had a significantly higher risk of all-cause death than those with APTT < 44 both before (HR (95% CI), 1.42 (1.16-1.74), P < 0.001) and after PSM (HR (95% CI), 1.47 (1.14-1.89), P = 0.003). The survival curves showed that patients with longer APTT had a significantly lower 1-year and 4-year cumulative survival probability. The ROC of APTT combined with other severity scores significantly increased predictive ability for 1-year and 4-year mortality.
Conclusions:
A longer APTT (≥44) was associated with a higher risk of mortality and can serve as a prognostic predictor in CABG patients.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins

